Publication | Closed Access

Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies

VaccinationVaccine SafetyDose LevelVaccination ScheduleVaccine EfficacyInfection ControlPhase 2MedicineVaccine ResearchEpidemiologyTick-borne Disease